Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice
Intervertebral disc degeneration is a leading cause of chronic back pain and disability. Here the authors show that long term treatment with senolytic compounds Dasatinib and Quercetin reduces disc senescence burden and ameliorates age-dependent degeneration in mice.
Saved in:
Main Authors: | Emanuel J. Novais, Victoria A. Tran, Shira N. Johnston, Kayla R. Darris, Alex J. Roupas, Garrett A. Sessions, Irving M. Shapiro, Brian O. Diekman, Makarand V. Risbud |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e824b98a87ac47fa8c57f62f8e079e2c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stem cell horizons in intervertebral disc degeneration
by: Joseph Ciacci, et al.
Published: (2009) -
Senolytic effects of quercetin in an in vitro model of pre-adipocytes and adipocytes induced senescence
by: Elena Zoico, et al.
Published: (2021) -
The Effects of Elgucare on Degenerated Intervertebral Disc-Induced Low Back Pain and Disc Regeneration: A Clinical Trial
by: Wen-Cheng Lo, et al.
Published: (2021) -
Preclinical development of a microRNA-based therapy for intervertebral disc degeneration
by: Ming-liang Ji, et al.
Published: (2018) -
(-)-Epigallocatechin-3-gallate Ameliorates Intervertebral Disc Degeneration Through Reprogramming of the Circadian Clock
by: Liangwei Mei, et al.
Published: (2021)